Memo3 IIoT Pharma Security evolves around an innovative application of near-infrared (NIR) scanners connected to a cloud. Depending on its chemical makeup, a target substance reflects a unique light pattern in the NIR spectrum. This can be captured and compared to a previously established model in the cloud. The result is a very reliable degree of certainty about the actual components of the target substance.
Initially hardware and software requirements are assessed and the solution tested with a rental device. This phase also includes a DD and building a business case for management decision.
During the next phase a secure, compliant, cloud-based database is established as the backbone of the solution. This can be provided or established within the customers environment. Data science and AI are used to build prediction models to capture the manufacturing variability of solid drugs of a given pharmaceutical company produced in different dosages, raw materials, and locations. In the field, a sample can be authenticated using a mobile analytical drug screening device containing a spectral sensor that transmits and within seconds receives the results utilizing the database via a smartphone app. The solution allows in principle anybody to verify a sample’s authenticity within minutes.
If the PoC is successful the roll-out and further integration in the organization is supported.
The large devices is applied at the manufacturing side and used for model generation and product QC or release
The portable scanner allows cost effective, large-scale decentral measurement.
The secure cloud environment manages models and users
Are you ready to take your brand protection strategy to the next level by ensuring product quality and authenticity on a global scale while also improving customer safety? Reach out now!